首页 > 最新文献

Le infezioni in medicina最新文献

英文 中文
Expanding the causes of Fever of Unknown Origin in immunocompromised patients: report of two cases highlighting the role of SARS-CoV-2. 扩大免疫功能低下患者不明原因发热的病因:两例病例报告强调SARS-CoV-2的作用
Pub Date : 2025-12-01 eCollection Date: 2025-01-01 DOI: 10.53854/liim-3304-10
Carmelina Calitri, Francesca Romano, Andrea Perinzano, Barbara Rizzello, Marco Domenico Carbutto, Fabio Antonino Ranzani, Roberto Angilletta, Marco Mussa, Andrea Calcagno

Fever of Unknown Origin (FUO) remains a diagnostic challenge for clinicians, with multiple infectious and non-infectious etiologies. SARS-CoV-2 can determine a prolonged viral shedding in the immunocompromised host, firstly in those receiving B-cell targeted therapies, being responsible of persistent infection which may configure as a FUO. We report two cases of long-lasting fever in patients with multiple sclerosis and B-cell depletion, finally diagnosed as COVID-19. We suggest the inclusion of SARS-CoV-2 testing in the differential diagnosis of FUO.

不明原因发热(FUO)仍然是临床医生的诊断挑战,具有多种感染性和非感染性病因。SARS-CoV-2可以在免疫功能低下的宿主中确定长期的病毒脱落,首先是在接受b细胞靶向治疗的宿主中,这是导致持续感染的原因,可能形成FUO。我们报告两例多发性硬化症和b细胞耗竭患者持续发热,最终诊断为COVID-19。我们建议将SARS-CoV-2检测纳入FUO的鉴别诊断。
{"title":"Expanding the causes of Fever of Unknown Origin in immunocompromised patients: report of two cases highlighting the role of SARS-CoV-2.","authors":"Carmelina Calitri, Francesca Romano, Andrea Perinzano, Barbara Rizzello, Marco Domenico Carbutto, Fabio Antonino Ranzani, Roberto Angilletta, Marco Mussa, Andrea Calcagno","doi":"10.53854/liim-3304-10","DOIUrl":"10.53854/liim-3304-10","url":null,"abstract":"<p><p>Fever of Unknown Origin (FUO) remains a diagnostic challenge for clinicians, with multiple infectious and non-infectious etiologies. SARS-CoV-2 can determine a prolonged viral shedding in the immunocompromised host, firstly in those receiving B-cell targeted therapies, being responsible of persistent infection which may configure as a FUO. We report two cases of long-lasting fever in patients with multiple sclerosis and B-cell depletion, finally diagnosed as COVID-19. We suggest the inclusion of SARS-CoV-2 testing in the differential diagnosis of FUO.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"33 4","pages":"448-452"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symptom-Based Active Tuberculosis Screening in Two Nigerian Correctional Facilities: A Cross-Sectional Study. 尼日利亚两所监狱中基于症状的主动肺结核筛查:一项横断面研究。
Pub Date : 2025-12-01 eCollection Date: 2025-01-01 DOI: 10.53854/liim-3304-3
Victor Abiola Adepoju, Olusola Daniel Sokoya, Safayet Jamil, Masoud Mohammadnezhad, Faisal Muhammad, Abdulrakib Abdulrahim, Hafiz T A Khan

Background: Tuberculosis (TB) remains a pressing health challenge in Nigerian correctional facilities, where the prevalence can be ten times higher than in the general population. Many facilities rely on passive TB case detection, often missing asymptomatic TB cases. This study evaluated a systematic active case-finding (ACF) approach using symptom-based screening followed by GeneXpert MTB/RIF testing across two high-volume Nigerian correctional facilities in Lagos and Ogun States.

Methods: Between April and September 2021, 2,244 inmates underwent standardized TB symptom screening (e.g., cough ≥2 weeks, weight loss, fever). Individuals with presumptive symptoms of TB provided sputum for GeneXpert analysis. The intervention comprised three strategies: (1) outreach screening in awaiting-trial mass cells, (2) cell-to-cell active case search, and (3) contact tracing of confirmed TB cases. Collected data were analysed to determine detection rates per 100,000 inmates and the overall positivity yield. Ethical clearance was obtained from the Lagos and Ogun State Ministries of Health, with formal permission granted by authorities of correctional facilities.

Results: Of the 2,244 inmates screened, 678 were identified as presumptive and tested, 45 were confirmed TB cases with estimated prevalence of 0.5% (approximately 489 per 100,000 inmates). The estimated prevalence is more than double the national prevalence 0.2% (219 per 100,000). The overall TB positivity rate among presumptive inmates was 7%. Inmates from Lagos recorded a TB point prevalence of 500 per 100,000, while prevalence in Ogun state was 458 per 100,000. A targeted outreach in one facility achieved a 32% TB yield. All detected TB cases were rifampicin-sensitive, and no drug-resistant strains was found in this cohort.

Conclusions: These findings highlight the effectiveness of symptom-based GeneXpert screening within correctional facilities which was substantially higher that conventional passive TB detection rates. All confirmed TB cases (n = 45) were rifampicin-sensitive, and no MDR or XDR strains were identified, an important observation in the prison environment. Regular, systematic ACF, especially in overcrowded and high-turnover environments, can significantly enhance early TB diagnosis and treatment initiation. Policymakers should institutionalize routine ACF in correctional facilities through universal entry screening for all new admissions and at least annual facility-wide screening, with symptom checklists plus rapid molecular testi. Where feasible, this should be combined with portable digital CXR/CAD triage alongside improvement in living conditions and post-release linkage to DOTS.

背景:结核病仍然是尼日利亚惩教机构面临的一项紧迫的卫生挑战,其患病率可能比一般人群高10倍。许多设施依靠被动的结核病病例检测,常常遗漏无症状结核病病例。本研究评估了系统主动病例发现(ACF)方法,该方法采用基于症状的筛查,然后在尼日利亚拉各斯州和奥贡州的两个高容量监狱进行GeneXpert MTB/RIF检测。方法:在2021年4月至9月期间,2244名囚犯接受了标准化的结核病症状筛查(例如,咳嗽≥2周,体重减轻,发烧)。假定有结核症状的个体提供了痰供GeneXpert分析。干预措施包括三个策略:(1)在等待试验的群体细胞中进行外展筛查,(2)细胞对细胞的活跃病例搜索,以及(3)追踪确诊结核病病例的接触者。对收集的数据进行分析,以确定每10万名囚犯的检出率和总体阳性率。获得了拉各斯州和奥贡州卫生部的道德许可,并得到了教养设施当局的正式许可。结果:在接受筛查的2244名囚犯中,678人被确定为推定和检测,45人被确诊为结核病病例,估计患病率为0.5%(约每10万名囚犯中有489人)。估计流行率是全国流行率0.2%(每10万人219人)的两倍多。假定囚犯的总体结核阳性率为7%。拉各斯囚犯的结核病点患病率为每10万人500人,而奥贡州的患病率为每10万人458人。在一个设施开展的有针对性的外展活动实现了32%的结核病产量。所有检测到的结核病例均对利福平敏感,在该队列中未发现耐药菌株。结论:这些发现突出了在教养设施中基于症状的GeneXpert筛查的有效性,其显着高于传统的被动结核病检出率。所有结核确诊病例(n = 45)均对利福平敏感,未发现MDR或XDR菌株,这是监狱环境中的一个重要观察结果。定期、系统的ACF,特别是在过度拥挤和高周转率的环境中,可以显著提高结核病的早期诊断和开始治疗。政策制定者应通过对所有新入院人员进行普遍的入境筛查和至少每年一次的全设施筛查,包括症状清单和快速分子检测,将常规ACF制度化。在可行的情况下,这应与便携式数字CXR/CAD分诊相结合,同时改善生活条件和释放后与DOTS的联系。
{"title":"Symptom-Based Active Tuberculosis Screening in Two Nigerian Correctional Facilities: A Cross-Sectional Study.","authors":"Victor Abiola Adepoju, Olusola Daniel Sokoya, Safayet Jamil, Masoud Mohammadnezhad, Faisal Muhammad, Abdulrakib Abdulrahim, Hafiz T A Khan","doi":"10.53854/liim-3304-3","DOIUrl":"10.53854/liim-3304-3","url":null,"abstract":"<p><strong>Background: </strong>Tuberculosis (TB) remains a pressing health challenge in Nigerian correctional facilities, where the prevalence can be ten times higher than in the general population. Many facilities rely on passive TB case detection, often missing asymptomatic TB cases. This study evaluated a systematic active case-finding (ACF) approach using symptom-based screening followed by GeneXpert MTB/RIF testing across two high-volume Nigerian correctional facilities in Lagos and Ogun States.</p><p><strong>Methods: </strong>Between April and September 2021, 2,244 inmates underwent standardized TB symptom screening (e.g., cough ≥2 weeks, weight loss, fever). Individuals with presumptive symptoms of TB provided sputum for GeneXpert analysis. The intervention comprised three strategies: (1) outreach screening in awaiting-trial mass cells, (2) cell-to-cell active case search, and (3) contact tracing of confirmed TB cases. Collected data were analysed to determine detection rates per 100,000 inmates and the overall positivity yield. Ethical clearance was obtained from the Lagos and Ogun State Ministries of Health, with formal permission granted by authorities of correctional facilities.</p><p><strong>Results: </strong>Of the 2,244 inmates screened, 678 were identified as presumptive and tested, 45 were confirmed TB cases with estimated prevalence of 0.5% (approximately 489 per 100,000 inmates). The estimated prevalence is more than double the national prevalence 0.2% (219 per 100,000). The overall TB positivity rate among presumptive inmates was 7%. Inmates from Lagos recorded a TB point prevalence of 500 per 100,000, while prevalence in Ogun state was 458 per 100,000. A targeted outreach in one facility achieved a 32% TB yield. All detected TB cases were rifampicin-sensitive, and no drug-resistant strains was found in this cohort.</p><p><strong>Conclusions: </strong>These findings highlight the effectiveness of symptom-based GeneXpert screening within correctional facilities which was substantially higher that conventional passive TB detection rates. All confirmed TB cases (n = 45) were rifampicin-sensitive, and no MDR or XDR strains were identified, an important observation in the prison environment. Regular, systematic ACF, especially in overcrowded and high-turnover environments, can significantly enhance early TB diagnosis and treatment initiation. Policymakers should institutionalize routine ACF in correctional facilities through universal entry screening for all new admissions and at least annual facility-wide screening, with symptom checklists plus rapid molecular testi. Where feasible, this should be combined with portable digital CXR/CAD triage alongside improvement in living conditions and post-release linkage to DOTS.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"33 4","pages":"382-390"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Halfway between Cure and Care: Suppressive Therapy in Inoperable Infective Endocarditis. 治疗与护理之间:不能手术的感染性心内膜炎的抑制治疗。
Pub Date : 2025-12-01 eCollection Date: 2025-01-01 DOI: 10.53854/liim-3304-6
Sergio Venturini, Ingrid Reffo, Laura Munaretto, Alessio Della Mattia, Giovanni Del Fabro, Astrid Callegari, Agnese Zanus-Fortes, Federico Giovagnorio, Daniela Pavan

Background: Infective endocarditis (IE) is a high-mortality condition that requires multidisciplinary expertise. In elderly patients with multiple comorbidities, surgery is often precluded by prohibitive risks or technical difficulties, leading to poor patient outcomes. Long-term suppressive antimicrobial therapy (SAT) is an alternative approach aimed at reducing relapse risk and maintaining clinical stability, with limited but growing evidence.

Methods: We conducted a retrospective, single-center observational study in northeastern Italy, that included 34 adult patients diagnosed with IE from January 1, 2020, to July 31, 2024. These patients were managed with SAT after completing a standard intravenous antimicrobial course and were either ineligible for curative surgery or had experienced failed surgical intervention, as determined by the Multidisciplinary Endocarditis Team (MET). The primary outcomes were all-cause mortality at the last available follow-up and documented infection relapse. Secondary outcomes included SAT characteristics (treatment duration, type of antimicrobial agent, discontinuation and its causes, and clinical course), as well as the occurrence of adverse drug events (ADEs) or tolerance issues attributable to SAT.

Results: The median age was 77 years (IQR 67-82), and the median Charlson Comorbidity Index was 6 (IQR 5-8). Prosthetic valve endocarditis (PVE) was the most common presentation, affecting 24 patients (70.6%). The blood culture positivity rate was 88.2%, with the main isolated microorganisms including staphylococci (13, 40.6% - mostly methicillin-susceptible Staphylococcus aureus - MSSA), streptococci (11, 34.4%), and Enterococcus faecalis (6, 18.8%). All-cause mortality during follow-up was 5/34 (14.7%), and the relapse rate was 4/34 (11.8%), all occurring during treatment. Median follow-up was 845 days (IQR 446-1488). ADEs affected 6/34 patients (17.6%), resulting in one hospitalization but without requiring treatment suspension. SAT was terminated by MET decision in 12 patients, with no subsequent relapses.

Conclusions: In non-operable IE patients, SAT has proven to be a feasible long-term strategy, weighing the risks of recurrence, drug-related events, and prolonged antibiotic exposure. Careful patient selection and strict follow-up are crucial.

背景:感染性心内膜炎(IE)是一种高死亡率的疾病,需要多学科的专业知识。在患有多种合并症的老年患者中,手术往往因风险过大或技术困难而被排除在外,导致患者预后不佳。长期抑制性抗菌药物治疗(SAT)是一种旨在降低复发风险和维持临床稳定性的替代方法,证据有限,但越来越多。方法:我们在意大利东北部进行了一项回顾性的单中心观察性研究,纳入了2020年1月1日至2024年7月31日诊断为IE的34名成年患者。多学科心内膜炎小组(MET)确定,这些患者在完成标准静脉抗菌疗程后接受SAT治疗,不符合治疗性手术条件或经历过失败的手术干预。主要结果是最后一次随访时的全因死亡率和记录的感染复发。次要结局包括SAT特征(治疗时间、抗菌药物类型、停药及其原因、临床病程),以及SAT引起的药物不良事件(ADEs)或耐受性问题的发生。结果:中位年龄为77岁(IQR 67-82),中位Charlson合并症指数为6 (IQR 5-8)。人工瓣膜心内膜炎(PVE)是最常见的表现,共24例(70.6%)。血培养阳性率为88.2%,主要分离微生物为葡萄球菌13株(40.6%),其中以甲氧西林敏感金黄色葡萄球菌(MSSA)为主,链球菌11株(34.4%),粪肠球菌6株(18.8%)。随访期间全因死亡率为5/34(14.7%),复发率为4/34(11.8%),均发生在治疗期间。中位随访为845天(IQR 446-1488)。ade影响了6/34例患者(17.6%),导致1例住院,但不需要暂停治疗。12例患者经MET决定终止SAT,无后续复发。结论:在不能手术的IE患者中,考虑到复发、药物相关事件和长期抗生素暴露的风险,SAT已被证明是一种可行的长期策略。仔细的患者选择和严格的随访至关重要。
{"title":"Halfway between Cure and Care: Suppressive Therapy in Inoperable Infective Endocarditis.","authors":"Sergio Venturini, Ingrid Reffo, Laura Munaretto, Alessio Della Mattia, Giovanni Del Fabro, Astrid Callegari, Agnese Zanus-Fortes, Federico Giovagnorio, Daniela Pavan","doi":"10.53854/liim-3304-6","DOIUrl":"10.53854/liim-3304-6","url":null,"abstract":"<p><strong>Background: </strong>Infective endocarditis (IE) is a high-mortality condition that requires multidisciplinary expertise. In elderly patients with multiple comorbidities, surgery is often precluded by prohibitive risks or technical difficulties, leading to poor patient outcomes. Long-term suppressive antimicrobial therapy (SAT) is an alternative approach aimed at reducing relapse risk and maintaining clinical stability, with limited but growing evidence.</p><p><strong>Methods: </strong>We conducted a retrospective, single-center observational study in northeastern Italy, that included 34 adult patients diagnosed with IE from January 1, 2020, to July 31, 2024. These patients were managed with SAT after completing a standard intravenous antimicrobial course and were either ineligible for curative surgery or had experienced failed surgical intervention, as determined by the Multidisciplinary Endocarditis Team (MET). The primary outcomes were all-cause mortality at the last available follow-up and documented infection relapse. Secondary outcomes included SAT characteristics (treatment duration, type of antimicrobial agent, discontinuation and its causes, and clinical course), as well as the occurrence of adverse drug events (ADEs) or tolerance issues attributable to SAT.</p><p><strong>Results: </strong>The median age was 77 years (IQR 67-82), and the median Charlson Comorbidity Index was 6 (IQR 5-8). Prosthetic valve endocarditis (PVE) was the most common presentation, affecting 24 patients (70.6%). The blood culture positivity rate was 88.2%, with the main isolated microorganisms including staphylococci (13, 40.6% - mostly methicillin-susceptible <i>Staphylococcus aureus</i> - MSSA), streptococci (11, 34.4%), and <i>Enterococcus faecalis</i> (6, 18.8%). All-cause mortality during follow-up was 5/34 (14.7%), and the relapse rate was 4/34 (11.8%), all occurring during treatment. Median follow-up was 845 days (IQR 446-1488). ADEs affected 6/34 patients (17.6%), resulting in one hospitalization but without requiring treatment suspension. SAT was terminated by MET decision in 12 patients, with no subsequent relapses.</p><p><strong>Conclusions: </strong>In non-operable IE patients, SAT has proven to be a feasible long-term strategy, weighing the risks of recurrence, drug-related events, and prolonged antibiotic exposure. Careful patient selection and strict follow-up are crucial.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"33 4","pages":"413-421"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695164/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Otitis media caused by Vibrio cholerae in a child: a case report and literature review. 儿童霍乱弧菌所致中耳炎1例报告并文献复习。
Pub Date : 2025-12-01 eCollection Date: 2025-01-01 DOI: 10.53854/liim-3304-11
Laura Venuti, Giulia La Malfa, Giulia Linares, Valeria Garbo, Giovanni Boncori, Sara Ashtari, Alessandra Cuccia, Chiara Albano, Giorgia Caruso, Alba Polizzi, Claudia Colomba

A previously healthy 12-year-old boy was brought to our attention due to worsening respiratory symptoms and persistent emesis. During hospitalization, the child developed right-sided otalgia followed by otorrhea. An otorhinolaryngologic exam revealed tympanic membrane perforation and discharge. An ear sample culture yielded Vibrio cholerae. A computed tomography scan confirmed the presence of otitis media complicated with otomastoiditis. Treatment with amoxicillin/clavulanate was complemented with ciprofloxacin and dexamethasone otic drops and led to a complete recovery without sequelae. While the child had no predisposing conditions, most published cases of otitis caused by Vibrio spp. describe a history of ear diseases or trauma and water exposure. In a context where vibriosis is increasingly common, our case exemplifies the importance of considering Vibrio spp. among the possible causative agents of otitis, especially in coastal areas or when exposure to potentially contaminated water cannot be ruled out, even in the absence of predisposing conditions.

一名原本健康的12岁男孩因呼吸道症状恶化和持续呕吐而引起我们的注意。住院期间,患儿出现右侧耳痛并伴有耳漏。耳鼻喉科检查发现鼓膜穿孔和分泌物。耳部样本培养产生霍乱弧菌。计算机断层扫描证实存在中耳炎合并耳乳突炎。阿莫西林/克拉维酸治疗补充环丙沙星和地塞米松滴剂,导致完全恢复无后遗症。虽然儿童没有易感条件,但大多数公布的由弧菌引起的中耳炎病例描述了耳部疾病或创伤和水暴露史。在弧菌病日益普遍的背景下,我们的病例说明了在可能的中耳炎病原体中考虑弧菌的重要性,特别是在沿海地区或暴露于潜在污染的水不能排除的情况下,即使没有易感条件。
{"title":"Otitis media caused by <i>Vibrio cholerae</i> in a child: a case report and literature review.","authors":"Laura Venuti, Giulia La Malfa, Giulia Linares, Valeria Garbo, Giovanni Boncori, Sara Ashtari, Alessandra Cuccia, Chiara Albano, Giorgia Caruso, Alba Polizzi, Claudia Colomba","doi":"10.53854/liim-3304-11","DOIUrl":"10.53854/liim-3304-11","url":null,"abstract":"<p><p>A previously healthy 12-year-old boy was brought to our attention due to worsening respiratory symptoms and persistent emesis. During hospitalization, the child developed right-sided otalgia followed by otorrhea. An otorhinolaryngologic exam revealed tympanic membrane perforation and discharge. An ear sample culture yielded <i>Vibrio cholerae</i>. A computed tomography scan confirmed the presence of otitis media complicated with otomastoiditis. Treatment with amoxicillin/clavulanate was complemented with ciprofloxacin and dexamethasone otic drops and led to a complete recovery without sequelae. While the child had no predisposing conditions, most published cases of otitis caused by <i>Vibrio spp.</i> describe a history of ear diseases or trauma and water exposure. In a context where vibriosis is increasingly common, our case exemplifies the importance of considering <i>Vibrio spp.</i> among the possible causative agents of otitis, especially in coastal areas or when exposure to potentially contaminated water cannot be ruled out, even in the absence of predisposing conditions.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"33 4","pages":"453-460"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High prevalence of dengue with warning signs but absence of severe cases in Vietnamese pediatric patients: an analysis of predictive factors. 越南儿科患者中有警示信号的登革热高流行率,但没有重症病例:预测因素分析
Pub Date : 2025-12-01 eCollection Date: 2025-01-01 DOI: 10.53854/liim-3304-5
Nhu Quynh Le, Hai Anh Nguyen, Khanh Huyen Vu, Khanh Linh Dang, Nang Trong Hoang, Thi Loi Dao, Van Thuan Hoang

Objectives: To identify the prevalence and potential predictive factors of severe dengue among children in Vietnam.

Methods: A retrospective study was conducted at Thai Binh Pediatric Hospital, in children from 0 to 16 years, hospitalized for dengue infection from January 2023 to December 2024. Dengue severity was classified according to WHO 2009 guidelines. Potential predictive factors of severe disease were investigated using logistic regression.

Results: A total of 332 children hospitalized for dengue infection were included: median age was 14 months and male gender accounted for 63.0% of the patients. 15.1% (n=50) presented with dengue with warning sign (DWS). None of the children developed severe dengue. The mean time from symptom onset to diagnosis of DWS was 4.0 ± 2.3 days. The most common clinical manifestations in DWS cases were right upper quadrant abdominal pain (34.0%), rapid decrease in platelet count (32.0%), and hepatomegaly (26.0%). Thrombocytopenia at admission was independent predictor (OR = 13.36, 95%CI [4.26-41.88]. Children older than five years and female patients also had higher odds of DWS (OR = 11.21, 95%CI [4.71-26.66] and OR = 2.32, 95%CI [1.05-5.13], respectively. Elevated hematocrit, hypoalbuminemia, elevated transaminases, abnormal nutritional status, petechiae and admission at ≥ 4 days from symptom onset were not associated with DWS after adjustment. The model achieved a sensitivity of 74% and a specificity of 92%, corresponding to an area under the receiver-operating-characteristic curve of 0.83, giving an overall accuracy of 89.5%.

Conclusions: Our findings identified predictive factors of DWS among children, especially low platelet count at admission is proposed as a practical tool for predicting DWS. This makes a practical tool for early risk stratification and resource allocation in settings with limited laboratory capacity in low- and middle-income countries.

目的:确定越南儿童重症登革热的流行情况和潜在的预测因素。方法:在泰平儿科医院对2023年1月至2024年12月因登革热感染住院的0至16岁儿童进行回顾性研究。根据世卫组织2009年指南对登革热严重程度进行了分类。采用logistic回归分析重症的潜在预测因素。结果:共纳入登革热感染住院患儿332例,中位年龄14个月,男性占63.0%。15.1% (n=50)出现登革热预警信号(DWS)。这些儿童都没有患上严重的登革热。从症状出现到诊断为DWS平均时间为4.0±2.3天。DWS患者最常见的临床表现为右上腹腹痛(34.0%)、血小板计数迅速减少(32.0%)、肝肿大(26.0%)。入院时血小板减少是独立预测因素(OR = 13.36, 95%CI[4.26-41.88])。5岁以上儿童和女性患者发生DWS的几率也较高(OR = 11.21, 95%CI[4.71 ~ 26.66]和OR = 2.32, 95%CI[1.05 ~ 5.13])。调整后,红细胞压积升高、低白蛋白血症、转氨酶升高、营养状况异常、瘀点和症状出现后≥4天入院与DWS无关。该模型的灵敏度为74%,特异性为92%,对应于接受者工作特征曲线下的面积为0.83,总体精度为89.5%。结论:我们的研究结果确定了儿童DWS的预测因素,特别是入院时低血小板计数被认为是预测DWS的实用工具。这使得在低收入和中等收入国家实验室能力有限的环境中,成为早期风险分层和资源分配的实用工具。
{"title":"High prevalence of dengue with warning signs but absence of severe cases in Vietnamese pediatric patients: an analysis of predictive factors.","authors":"Nhu Quynh Le, Hai Anh Nguyen, Khanh Huyen Vu, Khanh Linh Dang, Nang Trong Hoang, Thi Loi Dao, Van Thuan Hoang","doi":"10.53854/liim-3304-5","DOIUrl":"10.53854/liim-3304-5","url":null,"abstract":"<p><strong>Objectives: </strong>To identify the prevalence and potential predictive factors of severe dengue among children in Vietnam.</p><p><strong>Methods: </strong>A retrospective study was conducted at Thai Binh Pediatric Hospital, in children from 0 to 16 years, hospitalized for dengue infection from January 2023 to December 2024. Dengue severity was classified according to WHO 2009 guidelines. Potential predictive factors of severe disease were investigated using logistic regression.</p><p><strong>Results: </strong>A total of 332 children hospitalized for dengue infection were included: median age was 14 months and male gender accounted for 63.0% of the patients. 15.1% (n=50) presented with dengue with warning sign (DWS). None of the children developed severe dengue. The mean time from symptom onset to diagnosis of DWS was 4.0 ± 2.3 days. The most common clinical manifestations in DWS cases were right upper quadrant abdominal pain (34.0%), rapid decrease in platelet count (32.0%), and hepatomegaly (26.0%). Thrombocytopenia at admission was independent predictor (OR = 13.36, 95%CI [4.26-41.88]. Children older than five years and female patients also had higher odds of DWS (OR = 11.21, 95%CI [4.71-26.66] and OR = 2.32, 95%CI [1.05-5.13], respectively. Elevated hematocrit, hypoalbuminemia, elevated transaminases, abnormal nutritional status, petechiae and admission at ≥ 4 days from symptom onset were not associated with DWS after adjustment. The model achieved a sensitivity of 74% and a specificity of 92%, corresponding to an area under the receiver-operating-characteristic curve of 0.83, giving an overall accuracy of 89.5%.</p><p><strong>Conclusions: </strong>Our findings identified predictive factors of DWS among children, especially low platelet count at admission is proposed as a practical tool for predicting DWS. This makes a practical tool for early risk stratification and resource allocation in settings with limited laboratory capacity in low- and middle-income countries.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"33 4","pages":"404-412"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695169/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Black Death to COVID-19: Lessons Learned from the Past Pandemics. 从黑死病到COVID-19:从过去的大流行中吸取的教训。
Pub Date : 2025-12-01 eCollection Date: 2025-01-01 DOI: 10.53854/liim-3304-12
Sina Radparvar

Introduction: Throughout human history, pandemics such as Black Death, Smallpox, Spanish Flu and COVID-19 caused global outbreaks and spread of infectious pathogens resulting in significant morbidity and mortality. They also had profound social, cultural, political and economic effects. Various public health containment measures and treatment strategies were implemented in response to the outbreaks. Societal responses to the pandemics and the recommended control measures, though variable, followed common central themes over the centuries. Some of common themes included blaming outsiders or marginalized communities for the spread of diseases, defiance of public health measures, demands for change through social unrest, the spread of misinformation about diseases and unproven treatments, and complaints about healthcare disparities and socioeconomic inequalities.

Methods: Literature reviews were conducted via academic search engines Medline, Google Scholar, Web of Science and to identify pertinent historical and modern research and review articles related to the topic.

Results: The paper reviews the historical significance of the four pandemics, their pathophysiology, the public health strategies against the infectious agents and the psychosocial impacts of the outbreaks. The findings suggest that successful response to pandemic recurrences is not only driven by scientific advancements and government mandates but is also dependent on societal behavior and reactions as well as community environments and social determinants of health.

Discussion: Throughout previous pandemics, valuable lessons were overlooked, and little attention was placed on psychosocial factors. Understanding societal behaviors, human nature, disparities in socioeconomic status and inequalities can have a profound impact in combating the next pandemic.

导言:在整个人类历史上,黑死病、天花、西班牙流感和COVID-19等大流行病导致了传染性病原体的全球爆发和传播,导致了严重的发病率和死亡率。它们还产生了深刻的社会、文化、政治和经济影响。为应对疫情,实施了各种公共卫生控制措施和治疗战略。几个世纪以来,社会对流行病的反应和建议的控制措施虽然各不相同,但遵循着共同的中心主题。一些共同的主题包括将疾病的传播归咎于局外人或边缘化社区,蔑视公共卫生措施,要求通过社会动荡进行变革,传播有关疾病和未经证实的治疗的错误信息,以及抱怨医疗保健差距和社会经济不平等。方法:通过学术搜索引擎Medline、b谷歌Scholar、Web of Science进行文献综述,找出与该主题相关的历史和现代研究和综述文章。结果:本文综述了四次大流行的历史意义、病理生理学、公共卫生应对传染病的策略以及疫情的社会心理影响。研究结果表明,成功应对流行病复发不仅取决于科学进步和政府指令,还取决于社会行为和反应,以及社区环境和健康的社会决定因素。讨论:在以往的大流行中,宝贵的经验教训被忽视,对社会心理因素的关注很少。了解社会行为、人性、社会经济地位差异和不平等现象,可对防治下一次大流行病产生深远影响。
{"title":"From Black Death to COVID-19: Lessons Learned from the Past Pandemics.","authors":"Sina Radparvar","doi":"10.53854/liim-3304-12","DOIUrl":"10.53854/liim-3304-12","url":null,"abstract":"<p><strong>Introduction: </strong>Throughout human history, pandemics such as Black Death, Smallpox, Spanish Flu and COVID-19 caused global outbreaks and spread of infectious pathogens resulting in significant morbidity and mortality. They also had profound social, cultural, political and economic effects. Various public health containment measures and treatment strategies were implemented in response to the outbreaks. Societal responses to the pandemics and the recommended control measures, though variable, followed common central themes over the centuries. Some of common themes included blaming outsiders or marginalized communities for the spread of diseases, defiance of public health measures, demands for change through social unrest, the spread of misinformation about diseases and unproven treatments, and complaints about healthcare disparities and socioeconomic inequalities.</p><p><strong>Methods: </strong>Literature reviews were conducted via academic search engines Medline, Google Scholar, Web of Science and to identify pertinent historical and modern research and review articles related to the topic.</p><p><strong>Results: </strong>The paper reviews the historical significance of the four pandemics, their pathophysiology, the public health strategies against the infectious agents and the psychosocial impacts of the outbreaks. The findings suggest that successful response to pandemic recurrences is not only driven by scientific advancements and government mandates but is also dependent on societal behavior and reactions as well as community environments and social determinants of health.</p><p><strong>Discussion: </strong>Throughout previous pandemics, valuable lessons were overlooked, and little attention was placed on psychosocial factors. Understanding societal behaviors, human nature, disparities in socioeconomic status and inequalities can have a profound impact in combating the next pandemic.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"33 4","pages":"461-474"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695168/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deltoid Administration of LAI-ART: Pharmacokinetic Implications When the Gluteal Site Is Not Feasible. 三角肌给药:臀肌部位不可行时的药代动力学影响。
Pub Date : 2025-12-01 eCollection Date: 2025-01-01 DOI: 10.53854/liim-3304-9
Maria Vittoria Cossu, Antonio D'Avolio, Anna Lisa Ridolfo, Davide Moschese, Andrea Gori, Dario Cattaneo, Cristina Gervasoni

This case report describes the use of long-acting injectable (LAI) antiretrovirals administered via an alternative injection site in an individual with HIV who was unable to receive intramuscular gluteal injections. Specifically, it focuses on intensive pharmacokinetic monitoring following deltoid administration of LAI rilpivirine and cabotegravir in a 29-year-old transgender woman with progressive multifocal leukoencephalopathy and swallowing difficulties. Gluteal injection was contraindicated due to prior silicone injections in that region. Peak plasma concentrations were reached on day 3 post-injection for both drugs, with cabotegravir peaking at 1278 ng/mL and rilpivirine at 30 ng/mL. Rilpivirine plasma levels declined more rapidly than cabotegravir levels. By day 10, the patient's clinical condition had deteriorated, leading to hospice care and subsequent death. Rilpivirine exposure after deltoid injection appeared lower than that typically reported after gluteal or thigh administration, although intracellular drug concentrations may differ from plasma levels, potentially mitigating clinical concerns.

本病例报告描述了一名无法接受臀肌注射的艾滋病毒感染者通过替代注射部位使用长效可注射(LAI)抗逆转录病毒药物。具体而言,它侧重于对一名患有进行性多灶性白质脑病和吞咽困难的29岁变性女性进行LAI利匹韦林和卡波特韦三角肌给药后的强化药代动力学监测。臀注射是禁忌症,因为以前硅胶注射在该地区。两种药物的血药浓度均在注射后第3天达到峰值,卡波特韦的峰值为1278 ng/mL,利匹韦林的峰值为30 ng/mL。利匹韦林血浆水平下降的速度比头孢地韦更快。到第10天,患者的临床状况恶化,导致临终关怀和随后的死亡。三角肌注射后的利匹韦林暴露量似乎低于臀肌或大腿注射后的典型报告,尽管细胞内药物浓度可能与血浆水平不同,可能减轻临床担忧。
{"title":"Deltoid Administration of LAI-ART: Pharmacokinetic Implications When the Gluteal Site Is Not Feasible.","authors":"Maria Vittoria Cossu, Antonio D'Avolio, Anna Lisa Ridolfo, Davide Moschese, Andrea Gori, Dario Cattaneo, Cristina Gervasoni","doi":"10.53854/liim-3304-9","DOIUrl":"10.53854/liim-3304-9","url":null,"abstract":"<p><p>This case report describes the use of long-acting injectable (LAI) antiretrovirals administered via an alternative injection site in an individual with HIV who was unable to receive intramuscular gluteal injections. Specifically, it focuses on intensive pharmacokinetic monitoring following deltoid administration of LAI rilpivirine and cabotegravir in a 29-year-old transgender woman with progressive multifocal leukoencephalopathy and swallowing difficulties. Gluteal injection was contraindicated due to prior silicone injections in that region. Peak plasma concentrations were reached on day 3 post-injection for both drugs, with cabotegravir peaking at 1278 ng/mL and rilpivirine at 30 ng/mL. Rilpivirine plasma levels declined more rapidly than cabotegravir levels. By day 10, the patient's clinical condition had deteriorated, leading to hospice care and subsequent death. Rilpivirine exposure after deltoid injection appeared lower than that typically reported after gluteal or thigh administration, although intracellular drug concentrations may differ from plasma levels, potentially mitigating clinical concerns.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"33 4","pages":"445-447"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695167/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology and seroprevalence of Hepatitis E Virus in Nigeria and its African context: a review and one health perspective. 尼日利亚及其非洲地区戊型肝炎病毒的流行病学和血清阳性率:综述和一个健康观点。
Pub Date : 2025-12-01 eCollection Date: 2025-01-01 DOI: 10.53854/liim-3304-2
Babatunde Ibrahim Olowu, Oluwaloni Bolaji Tinubu, Oluwatomisin Omolola Solesi, Emmanuel Ochi, Saheed Olaide Ahmed, Maryam Ebunoluwa Zakariya

Hepatitis E virus (HEV) is an under-recognised cause of acute viral hepatitis and remains a major public health concern in Africa. Worldwide, over 20 million HEV infections and nearly 3 million symptomatic cases occur annually, but the true extent in Africa is poorly understood due to limited surveillance, inconsistent diagnostics, gaps in blood safety, unclear zoonotic routes, low public awareness, and underreporting. Outbreaks in several African countries are often associated with floods, displacement, and poor sanitation. Seroprevalence studies show notable variation, from less than 1% in Tanzania to over 80% in Egypt, reflecting diverse epidemiological situations across the continent. In Nigeria, two major outbreaks have been reported, with evidence of widespread human exposure and high infection rates in pigs. Addressing these issues requires a One Health approach that integrates human, veterinary, and environmental health systems. Priority interventions include expanding affordable diagnostics, strengthening Water, Sanitation and Hygiene (WASH) infrastructure, routine animal and blood donor screening, targeted education for high-risk groups, and investment in molecular epidemiology. Therefore, this review consolidates current knowledge of HEV in Africa, with insights from Nigeria, and provides recommendations for control through a coordinated One Health approach.

戊型肝炎病毒(HEV)是一种未得到充分认识的急性病毒性肝炎病因,在非洲仍然是一个主要的公共卫生问题。在世界范围内,每年发生2000多万例戊肝病毒感染和近300万例有症状病例,但由于监测有限、诊断不一致、血液安全存在差距、人畜共患病途径不明确、公众意识低下和漏报,非洲的真实情况鲜为人知。在一些非洲国家暴发的疫情往往与洪水、流离失所和卫生条件差有关。血清流行率研究显示出显著差异,从坦桑尼亚的不到1%到埃及的80%以上,反映了整个非洲大陆不同的流行病学情况。在尼日利亚,报告了两次重大疫情,有证据表明人类广泛接触,猪的感染率很高。解决这些问题需要“同一个健康”方法,将人类、兽医和环境卫生系统整合在一起。重点干预措施包括扩大负担得起的诊断方法,加强水、环境卫生和个人卫生基础设施,对动物和献血者进行常规筛查,对高危人群进行有针对性的教育,以及对分子流行病学进行投资。因此,本综述结合尼日利亚的见解,巩固了非洲目前对HEV的了解,并提供了通过协调一致的“同一个健康”方法进行控制的建议。
{"title":"Epidemiology and seroprevalence of Hepatitis E Virus in Nigeria and its African context: a review and one health perspective.","authors":"Babatunde Ibrahim Olowu, Oluwaloni Bolaji Tinubu, Oluwatomisin Omolola Solesi, Emmanuel Ochi, Saheed Olaide Ahmed, Maryam Ebunoluwa Zakariya","doi":"10.53854/liim-3304-2","DOIUrl":"10.53854/liim-3304-2","url":null,"abstract":"<p><p>Hepatitis E virus (HEV) is an under-recognised cause of acute viral hepatitis and remains a major public health concern in Africa. Worldwide, over 20 million HEV infections and nearly 3 million symptomatic cases occur annually, but the true extent in Africa is poorly understood due to limited surveillance, inconsistent diagnostics, gaps in blood safety, unclear zoonotic routes, low public awareness, and underreporting. Outbreaks in several African countries are often associated with floods, displacement, and poor sanitation. Seroprevalence studies show notable variation, from less than 1% in Tanzania to over 80% in Egypt, reflecting diverse epidemiological situations across the continent. In Nigeria, two major outbreaks have been reported, with evidence of widespread human exposure and high infection rates in pigs. Addressing these issues requires a One Health approach that integrates human, veterinary, and environmental health systems. Priority interventions include expanding affordable diagnostics, strengthening Water, Sanitation and Hygiene (WASH) infrastructure, routine animal and blood donor screening, targeted education for high-risk groups, and investment in molecular epidemiology. Therefore, this review consolidates current knowledge of HEV in Africa, with insights from Nigeria, and provides recommendations for control through a coordinated One Health approach.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"33 4","pages":"370-381"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burden of neonatal pneumonia and risk factors for severe disease in low - and middle - income country. 低收入和中等收入国家新生儿肺炎负担和严重疾病的危险因素。
Pub Date : 2025-12-01 eCollection Date: 2025-01-01 DOI: 10.53854/liim-3304-8
Minh Manh To, Thi Quynh Nga Nguyen, Duc Long Phi, Van Lap Khuc, Nhu Quynh Le, Khanh Linh Dang, Khanh Huyen Truong, Trong Kiem Tran, Thanh Tam Nguyen, Manh Tuong Nguyen, Phuong Thuy Nguyen Dang, Van Thuan Hoang, Thi Loi Dao

Objectives: To determine morbidity, mortality, and risk factors of severe disease requiring invasive mechanical ventilation (IMV) in neonates with pneumonia in rural Vietnam.

Methods: A retrospective study was conducted and included all neonates (<28 days) admitted with pneumonia between January and December 2024. Demographics, clinical features, and laboratory results were extracted from standardized patient charts. Univariable and multivariable logistic regression were used to identify independent risk factors for IMV.

Results: Of 1,034 admissions, 612 (59.2%) met pneumonia criteria; mortality rate was 0.2%. Median age at admission was 17 days (IQR 12-23), and 61.6 % were boys. Preterm birth and low birth weight occurred in 4.6% and 6.4% of cases, respectively. Tachypnoea (96.1%), wheeze (93.0%), and signs of respiratory distress (37.7%) were predominant. Abnormal neutrophil counts were observed in 30.2%, and 5.2% had C-reactive protein (CRP) ≥10 mg/L. Independent risk factors for IMV were younger age (adjusted odds ratio [aOR] 0.88 per day; 95% CI 0.85-0.92), neurological symptoms (aOR 24.0; 95% CI 4.07-141.67), and CRP ≥10 mg/L (aOR 3.23; 95% CI 1.22-8.52).

Conclusions: Pneumonia remains a major cause of neonatal morbidity in rural Vietnam, though mortality is low. Younger age, neurological compromise, and elevated CRP identify neonates at greatest risk for requiring IMV. Incorporating these factors into admission triage may streamline escalation of care and optimize resource allocation in neonatal units.

目的:确定越南农村肺炎新生儿需要有创机械通气(IMV)的严重疾病的发病率、死亡率和危险因素。方法:对所有新生儿进行回顾性研究(结果:1034例入院患者中,612例(59.2%)符合肺炎标准;死亡率为0.2%。入院时中位年龄为17天(IQR 12-23), 61.6%为男孩。早产和低出生体重分别占4.6%和6.4%。以呼吸急促(96.1%)、喘息(93.0%)和呼吸窘迫(37.7%)为主。中性粒细胞计数异常占30.2%,c反应蛋白(CRP)≥10 mg/L占5.2%。IMV的独立危险因素为年龄更小(校正优势比[aOR] 0.88 /天;95% CI 0.85-0.92)、神经症状(aOR 24.0; 95% CI 4.07-141.67)和CRP≥10 mg/L (aOR 3.23; 95% CI 1.22-8.52)。结论:肺炎仍然是越南农村新生儿发病的主要原因,尽管死亡率很低。年龄较小、神经系统受损和CRP升高是需要IMV的高危新生儿。将这些因素纳入入院分诊可以简化护理升级并优化新生儿病房的资源分配。
{"title":"Burden of neonatal pneumonia and risk factors for severe disease in low - and middle - income country.","authors":"Minh Manh To, Thi Quynh Nga Nguyen, Duc Long Phi, Van Lap Khuc, Nhu Quynh Le, Khanh Linh Dang, Khanh Huyen Truong, Trong Kiem Tran, Thanh Tam Nguyen, Manh Tuong Nguyen, Phuong Thuy Nguyen Dang, Van Thuan Hoang, Thi Loi Dao","doi":"10.53854/liim-3304-8","DOIUrl":"10.53854/liim-3304-8","url":null,"abstract":"<p><strong>Objectives: </strong>To determine morbidity, mortality, and risk factors of severe disease requiring invasive mechanical ventilation (IMV) in neonates with pneumonia in rural Vietnam.</p><p><strong>Methods: </strong>A retrospective study was conducted and included all neonates (<28 days) admitted with pneumonia between January and December 2024. Demographics, clinical features, and laboratory results were extracted from standardized patient charts. Univariable and multivariable logistic regression were used to identify independent risk factors for IMV.</p><p><strong>Results: </strong>Of 1,034 admissions, 612 (59.2%) met pneumonia criteria; mortality rate was 0.2%. Median age at admission was 17 days (IQR 12-23), and 61.6 % were boys. Preterm birth and low birth weight occurred in 4.6% and 6.4% of cases, respectively. Tachypnoea (96.1%), wheeze (93.0%), and signs of respiratory distress (37.7%) were predominant. Abnormal neutrophil counts were observed in 30.2%, and 5.2% had C-reactive protein (CRP) ≥10 mg/L. Independent risk factors for IMV were younger age (adjusted odds ratio [aOR] 0.88 per day; 95% CI 0.85-0.92), neurological symptoms (aOR 24.0; 95% CI 4.07-141.67), and CRP ≥10 mg/L (aOR 3.23; 95% CI 1.22-8.52).</p><p><strong>Conclusions: </strong>Pneumonia remains a major cause of neonatal morbidity in rural Vietnam, though mortality is low. Younger age, neurological compromise, and elevated CRP identify neonates at greatest risk for requiring IMV. Incorporating these factors into admission triage may streamline escalation of care and optimize resource allocation in neonatal units.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"33 4","pages":"435-444"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695165/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Imipenem/Cilastatin/Relebactam in infections caused by Difficult-to-Treat Gram-Negative Bacteria: A Retrospective Analysis of Real-world data in Greece. 亚胺培南/西司他汀/瑞巴坦治疗难治性革兰氏阴性菌感染的疗效:对希腊真实世界数据的回顾性分析
Pub Date : 2025-12-01 eCollection Date: 2025-01-01 DOI: 10.53854/liim-3304-7
Vasileios Petrakis, Petros Rafailidis, Maria Panopoulou, Theocharis Konstantinidis, Nikoleta Babaka, Dimitrios Papazoglou, Periklis Panagopoulos

Background: The escalating global crisis of antimicrobial resistance (AMR), particularly among multidrug-resistant (MDR) Gram-negative bacteria (GNB), presents a significant challenge to patient care. Newer β-lactam/β-lactamase inhibitor (BL/BLI) combinations, such as imipenem/cilastatin/relebactam (IMI/REL), have been developed to overcome key resistance mechanisms, including those mediated by KPC and AmpC enzymes, offering new hope for treating severe infections with limited therapeutic options.

Patients and methods: This was a retrospective, single-center, observational study of 195 adult patients with GNB bacteraemia who received IMI/REL for at least 48 hours. The patient cohort was characterized by a high comorbidity burden (median Charlson Comorbidity Index of 4) and significant illness severity (median APACHE II score of 14). The most common pathogens were Pseudomonas aeruginosa (63.1%) and Klebsiella pneumoniae (24.6%), with a high proportion of isolates being carbapenem-non-susceptible (77.5%). The primary outcome was clinical success, and secondary outcomes included 30-day all-cause mortality and safety.

Results: The overall clinical success rate was 72.82%, and the all-cause 30-day mortality rate was 11.3%. Microbiologic failure occurred in 12.3% of patients, and infection recurrence within 30 days was seen in 8.2%. The safety profile was favourable, with adverse drug reactions reported in 4.1% of patients, leading to treatment discontinuation in only two cases (1.02%).

Conclusions: The findings of this study reinforce the value of IMI/REL as an effective and well-tolerated treatment for severe GNB infections in a complex, real-world patient population. These outcomes compare favourably with published data for other new BL/BLI agents, supporting the targeted use of IMI/REL as a crucial component of modern antibiotic stewardship.

背景:不断升级的全球抗微生物药物耐药性危机,特别是在耐多药革兰氏阴性菌(MDR)中,对患者护理提出了重大挑战。较新的β-内酰胺/β-内酰胺酶抑制剂(BL/BLI)组合,如亚胺培南/西司他汀/乐巴坦(IMI/REL),已经被开发出来,以克服关键的耐药机制,包括由KPC和AmpC酶介导的耐药机制,为治疗有限的严重感染提供了新的希望。患者和方法:这是一项回顾性、单中心、观察性研究,纳入195例接受IMI/REL治疗至少48小时的GNB菌血症成年患者。患者队列的特点是共病负担高(Charlson共病指数中位数为4)和疾病严重程度显著(APACHE II评分中位数为14)。最常见的病原菌为铜绿假单胞菌(63.1%)和肺炎克雷伯菌(24.6%),碳青霉烯不敏感的分离菌比例较高(77.5%)。主要结局是临床成功,次要结局包括30天全因死亡率和安全性。结果:临床总成功率为72.82%,全因30天死亡率为11.3%。12.3%的患者出现微生物学失败,8.2%的患者在30天内出现感染复发。安全性良好,4.1%的患者报告了药物不良反应,仅2例(1.02%)导致停药。结论:本研究的结果强化了IMI/REL作为复杂的现实世界患者群体中严重GNB感染的有效且耐受性良好的治疗方法的价值。这些结果与已发表的其他新型BL/BLI药物的数据相比较有利,支持将IMI/REL作为现代抗生素管理的关键组成部分进行有针对性的使用。
{"title":"Efficacy of Imipenem/Cilastatin/Relebactam in infections caused by Difficult-to-Treat Gram-Negative Bacteria: A Retrospective Analysis of Real-world data in Greece.","authors":"Vasileios Petrakis, Petros Rafailidis, Maria Panopoulou, Theocharis Konstantinidis, Nikoleta Babaka, Dimitrios Papazoglou, Periklis Panagopoulos","doi":"10.53854/liim-3304-7","DOIUrl":"10.53854/liim-3304-7","url":null,"abstract":"<p><strong>Background: </strong>The escalating global crisis of antimicrobial resistance (AMR), particularly among multidrug-resistant (MDR) Gram-negative bacteria (GNB), presents a significant challenge to patient care. Newer β-lactam/β-lactamase inhibitor (BL/BLI) combinations, such as imipenem/cilastatin/relebactam (IMI/REL), have been developed to overcome key resistance mechanisms, including those mediated by KPC and AmpC enzymes, offering new hope for treating severe infections with limited therapeutic options.</p><p><strong>Patients and methods: </strong>This was a retrospective, single-center, observational study of 195 adult patients with GNB bacteraemia who received IMI/REL for at least 48 hours. The patient cohort was characterized by a high comorbidity burden (median Charlson Comorbidity Index of 4) and significant illness severity (median APACHE II score of 14). The most common pathogens were <i>Pseudomonas aeruginosa</i> (63.1%) and <i>Klebsiella pneumoniae</i> (24.6%), with a high proportion of isolates being carbapenem-non-susceptible (77.5%). The primary outcome was clinical success, and secondary outcomes included 30-day all-cause mortality and safety.</p><p><strong>Results: </strong>The overall clinical success rate was 72.82%, and the all-cause 30-day mortality rate was 11.3%. Microbiologic failure occurred in 12.3% of patients, and infection recurrence within 30 days was seen in 8.2%. The safety profile was favourable, with adverse drug reactions reported in 4.1% of patients, leading to treatment discontinuation in only two cases (1.02%).</p><p><strong>Conclusions: </strong>The findings of this study reinforce the value of IMI/REL as an effective and well-tolerated treatment for severe GNB infections in a complex, real-world patient population. These outcomes compare favourably with published data for other new BL/BLI agents, supporting the targeted use of IMI/REL as a crucial component of modern antibiotic stewardship.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"33 4","pages":"422-434"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695162/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Le infezioni in medicina
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1